| Investigation of the Impact of CYP3A5 Polymorphism on Drug–Drug Interaction between Tacrolimus and Schisantherin A/Schisandrin A Based on Physiologically … Q He, F Bu, H Zhang, Q Wang, Z Tang, J Yuan, HS Lin, X Xiang Pharmaceuticals 14 (3), 198, 2021 | 18 | 2021 |
| Research and development of Chinese anti-COVID-19 drugs X Ji, X Meng, X Zhu, Q He, Y Cui Acta Pharmaceutica Sinica B 12 (12), 4271-4286, 2022 | 17 | 2022 |
| Real-world safety of PCSK9 inhibitors: A pharmacovigilance study based on spontaneous reports in FAERS Z Feng, X Li, WK Tong, Q He, X Zhu, X Xiang, Z Tang Frontiers in Pharmacology 13, 894685, 2022 | 14 | 2022 |
| Predicting drug-drug interactions with physiologically based pharmacokinetic/pharmacodynamic modelling and optimal dosing of apixaban and rivaroxaban with dronedarone co … HN Wen, QF He, XQ Xiang, Z Jiao, JG Yu Thrombosis Research 218, 24-34, 2022 | 11 | 2022 |
| Examination of the impact of CYP3A4/5 on drug–drug interaction between schizandrol a/schizandrol b and tacrolimus (FK-506): a physiologically based pharmacokinetic modeling … Q He, F Bu, Q Wang, M Li, J Lin, Z Tang, WY Mak, X Zhuang, X Zhu, ... International Journal of Molecular Sciences 23 (9), 4485, 2022 | 11 | 2022 |
| Application of physiologically based pharmacokinetic modeling in preclinical studies: A feasible strategy to practice the principles of 3Rs Y Yuan, Q He, S Zhang, M Li, Z Tang, X Zhu, Z Jiao, W Cai, X Xiang Frontiers in Pharmacology 13, 895556, 2022 | 9 | 2022 |
| Application of physiologically based pharmacokinetic modelling for the prediction of drug–drug interactions involving anlotinib as a perpetrator of cytochrome P450 enzymes Z Jin, Q He, X Zhu, M Zhu, Y Wang, X Wu, Q Lv, X Xiang Basic & Clinical Pharmacology & Toxicology 130 (5), 592-605, 2022 | 9 | 2022 |
| Validation of the Simplified Chinese Version of the Brief Diabetes Quality of Life (DQoL) Questionnaire based on a cross-sectional study Z Tang, X Jiang, L Hong, Z Feng, Q He, J Yuan, X Xiang International Journal of Environmental Research and Public Health 17 (23), 8792, 2020 | 9 | 2020 |
| Machine learning techniques for CT imaging diagnosis of novel coronavirus pneumonia: a review J Chen, Y Li, L Guo, X Zhou, Y Zhu, Q He, H Han, Q Feng Neural Computing and Applications 36 (1), 181-199, 2024 | 8 | 2024 |
| Escitalopram personalized dosing: a population pharmacokinetics repository method X Liu, G Ju, W Yang, L Chen, N Xu, Q He, X Zhu, D Ouyang Drug Design, Development and Therapy, 2955-2967, 2023 | 5 | 2023 |
| Covalent binding mechanism of furmonertinib and osimertinib with human serum albumin Y Wu, L Chen, J Chen, H Xue, Q He, D Zhong, X Diao Drug Metabolism and Disposition 51 (1), 8-16, 2023 | 5 | 2023 |
| Model-informed drug development of new cefoperazone sodium and sulbactam sodium combination (3: 1): Pharmacokinetic/pharmacodynamic analysis and antibacterial efficacy against … XW Ji, X Zhu, Y Li, F Xue, IHS Kuan, QF He, XR Meng, XQ Xiang, YM Cui, ... Frontiers in Pharmacology 13, 856792, 2022 | 5 | 2022 |
| Simultaneous Quantitation of S (+)-and R (−)-Baclofen and Its Metabolite in Human Plasma and Cerebrospinal Fluid using LC–APCI–MS/MS: An Application for Clinical Studies Q He, YS Chhonker, MJ McLaughlin, DJ Murry Molecules 25 (2), 250, 2020 | 5 | 2020 |
| Establishment and evaluation of a parametric population pharmacokinetic model repository for ganciclovir and valganciclovir W Yang, W Mak, A Gwee, M Gu, Y Wu, Y Shi, Q He, X Xiang, B Han, ... Pharmaceutics 15 (7), 1801, 2023 | 4 | 2023 |
| Applications of in silico models to predict drug-induced liver injury J Lin, M Li, W Mak, Y Shi, X Zhu, Z Tang, Q He, X Xiang Toxics 10 (12), 788, 2022 | 4 | 2022 |
| Simultaneous Quantification of Propylthiouracil and Its N-β-d Glucuronide by HPLC-MS/MS: Application to a Metabolic Study M Li, Q He, L Yao, X Wang, Z Tang, X Zhu, HS Lin, X Xiang Pharmaceuticals 14 (11), 1194, 2021 | 4 | 2021 |
| Evaluating the impact of co-administered drug and disease on ripretinib exposure: A physiologically-based pharmacokinetic modeling approach C Pan, Y Cheng, Q He, M Li, F Bu, X Zhu, X Li, X Xiang Chemico-Biological Interactions 373, 110400, 2023 | 3 | 2023 |
| Utilization of physiologically based pharmacokinetic modeling in pharmacokinetic study of natural medicine: an overview Q Jia, Q He, L Yao, M Li, J Lin, Z Tang, X Zhu, X Xiang Molecules 27 (24), 8670, 2022 | 3 | 2022 |
| Escitalopram population pharmacokinetics and remedial strategies based on CYP2C19 phenotype X Liu, G Ju, X Huang, W Yang, L Chen, C Li, Q He, N Xu, X Zhu, ... Journal of Affective Disorders 346, 64-74, 2024 | 2 | 2024 |
| Population pharmacokinetics of Amisulpride in Chinese patients with schizophrenia with external validation: the impact of renal function A Li, WY Mak, T Ruan, F Dong, N Zheng, M Gu, W Guo, J Zhang, H Cheng, ... Frontiers in Pharmacology 14, 1215065, 2023 | 2 | 2023 |
